Aromando Andrew bought ONCY
February 11, 2026 · Form 4 insider transaction
Aromando Andrew bought 29,600 shares of Oncolytics Biotech Inc. at $0.86 per share, a transaction worth $25.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
29,600
Price
$0.86
Total value
$25.4K
InsiderAromando Andrew
RoleOfficer
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after55,100
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.85 to $0.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.